iCell Gene Therapeutics Revenue

Biotechnology Research • Stony Brook University, New York, United States • 1-10 Employees

iCell Gene Therapeutics revenue & valuation

Annual revenue	$855,550
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,800,000
Total funding	No funding

Key Contacts at iCell Gene Therapeutics

Jennifer Chow

Chief Executive Officer

Byeong Hyeok Choi

R&D Director

Yupo Ma

Founder And Chairman Of The Board

Company overview

Headquarters	25 Health Sciences Dr, Stony Brook, New York 11790, US
Website	icellgene.com
SIC	873
Founded	2014
Employees	1-10
Socials

iCell Gene Therapeutics Email Formats

iCell Gene Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@icellgene.com), used 66.7% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@icellgene.com	66.7%
{first name}.{last name}	john.doe@icellgene.com	33.3%

About iCell Gene Therapeutics

iCell Gene Therapeutics is a clinical-stage biopharmaceutical company developing chimeric antigen receptor (CAR) immunotherapies designed to be innovative, first-in-class and lifesaving. We are focused on developing treatments for diseases where no treatment options exist and where dramatic increases in quality and duration of life are needed, including autoimmune disorders, AML, and T-cell malignancies. We are currently conducting clinical trials in the U.S. and China utilizing our CARvac, T-cell targeted CARs, compound CARs and non-gene edited universal CARs engineered as treatments for autoimmune diseases, cancer, and organ rejections. For more information, please visit http://icellgene.com/

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

C-Suite

Director

Employees by Department

iCell Gene Therapeutics has 5 employees across 4 departments.

Departments

Number of employees

Funding Data

iCell Gene Therapeutics has never raised funding before.

iCell Gene Therapeutics Tech Stack

Discover the technologies and tools that power iCell Gene Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

reCAPTCHA

Security

Squarespace Commerce

Ecommerce

Stimulus

JavaScript frameworks

Bluehost

Hosting

Open Graph

Miscellaneous

HSTS

Security

core-js

JavaScript libraries

Cart Functionality

Ecommerce

YUI

JavaScript libraries

Squarespace

CMS

Frequently asked questions

iCell Gene Therapeutics is located in Stony Brook University, New York, US.

iCell Gene Therapeutics generates an estimated annual revenue of $855,550. This revenue figure reflects the company's market position and business performance in its industry.

iCell Gene Therapeutics has an estimated valuation of $2,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

iCell Gene Therapeutics was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

iCell Gene Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at iCell Gene Therapeutics

Jennifer Chow

Chief Executive Officer

Byeong Hyeok Choi

R&D Director

Yupo Ma

Founder And Chairman Of The Board

4.8

40,000 users